Features of Cerebral Demyelination and Clinical Relevance in Systemic Lupus Erythematosus
Qulian Guo,Yang He,Xia Liu,Xu Gao,Jing Xu,Xue Li,Yue Sun,Yajuan Xiang,Ru Li,Zhanguo Li
DOI: https://doi.org/10.21203/rs.3.rs-685756/v1
2021-01-01
Abstract:We aimed to explore the clinical features and cerebral magnetic resonance imaging (MRI) changes of central nervous system demyelination in systemic lupus erythematosus (SLE) patients. Based on a consecutive cohort of 1191 SLE patients, 273 patients with cerebral MRI were enrolled to assess cerebral demyelination. Patients were divided into two groups, ie. complicated with or without demyelination. The MRI findings of the cerebral demyelination were divided into three categories: type A, periventricular white matter (WM) lesions; type B, subcortical WM lesions; type C, multiple discrete WM lesions. Among the 273 SLE patients with cerebral MRI, 35.9% (98/273) had demyelinating changes. The incidences of type A, B and C were 54.1% (53/98), 11.2% (11/98) and 92.9% (91/98), respectively. Fifty-one percent of the patients were with overlap of 2 or 3 types. Type C was the most common subgroup combined with other types. Compared with those without demyelination, the patients with demyelination were more likely to develop neuropsychiatric systemic lupus erythematosus (NPSLE), lupus nephritis (LN), hypertension and hyperuricemia ( p < 0.05). Significantly higher rates of polyserous effusions and cardiac involvement were found in the patients with demyelination ( p < 0.05). In addition, the patients with demyelination had higher frequency of proteinuria and higher levels of CD8 + T cells ( p < 0.05). In multivariate logistic analysis, hyperuricemia and higher CD8 + T cells were significantly correlated with demyelination in SLE patients ( p < 0.05). The data suggest that demyelination is a common complication in SLE patients and strongly associated with systemic involvements, including NPSLE, LN, polyserous effusions and cardiac involvement. Hyperuricemia and higher CD8 + T cells were independent risk factors for demyelination in SLE.